Antiaging Quantum Living FY27 Q1 net loss widens 138.81% to $318,509; revenue more than doubled to $730,117

• Antiaging Quantum Living posted revenue of $730,117 for the quarter ended June 30, 2026, more than doubled from a year earlier.
• Net loss widened to $318,509, up 138.81% year over year, as selling, general and administrative expenses climbed 70.53% to $635,966.
• Gross margin fell 37.69 percentage points to 42.85% as revenue shifted from legacy online platform services to health/beauty products.
• Revenue was generated entirely from proprietary health/beauty products of $743,969; therapy services recorded $(13,852) following the phase-out of platform services.
• Cash and cash equivalents totaled about $608,100 at June 30, 2026; management flagged substantial doubt about going concern, citing operating losses and cash outflows.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Antiaging Quantum Living Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038392), on August 14, 2026, and is solely responsible for the information contained therein.